|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4709 | (2006.01) |
| A61K 31/4706 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3000467 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15188350.1 |
| Date of filing the European patent application | 2010-03-24 | |
| (97) | Date of publication of the European application | 2016-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-01 |
| (46) | Date of publication of the claims translation | 2023-04-11 |
| (30) | Number | Date | Country code |
| 166796 P | 2009-04-06 | US |
| (72) |
BERKENBLIT, Anna , US
BINLICH, Florence , FR
GOSS, Paul , US
|
| (73) |
Wyeth LLC ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Krūties vėžio gydymo schema naudojant neratinibą |
| TREATMENT REGIMEN UTILIZING NERATINIB FOR BREAST CANCER |
| Payment date | Validity (years) | Amount | |
| 2026-02-23 | 17 | 347.00 EUR |
| 2027-03-24 |